Lactulose

When ATH:
A06AD11

Characteristic.

White powder, soluble in water. As impurities may contain galactose (no more 16%), laktozu (12%), epilaktozu (8%), fructose (1%).

Pharmacological action.
Stimulating peristalsis, laxative, hypoazotemic.

Application.

Constipation (incl. chronic); the need to soften the stool for medical purposes (hemorrhoids, need surgery on the colon and / or anal, pain after the removal of hemorrhoids, postoperatively); hepatic encephalopathy, including to whom and Preko (Treatment and Prevention); ammoniemia; intestinal dysbiosis; enteritis, by salmonella, şigellami, salmonellonositelstvo; putrid dyspepsia syndrome (in infants as a result of acute food poisoning).

Contraindications.

Hypersensitivity, galactosemia, bowel obstruction, rectal bleeding (the cause of which is not hemorrhoids), round- or ileostomy, suspected appendicitis.

Pregnancy and breast-feeding.

Category actions result in FDA - B. (The study of reproduction in animals revealed no risk of adverse effects on the fetus, and adequate and well-controlled studies in pregnant women have not done.)

Side effects.

Flatulence, diarrhea, abdominal pain, loss of electrolytes.

Cooperation.

Antibiotics (neomycin) and non-absorbable antacids reduce the effect of.

Overdose.

Symptoms: diarrhea, abdominal pain.

Treatment: the drug should be discontinued.

Dosing and Administration.

Inside. Dose set individually. When liver encephalopathy adults appoint up to 45-90 ml of syrup in 2-3 reception (up to 90-190 ml/day), for other indications — 15-45 mL/day. Children over 1 year 5-15 ml/day, younger 1 year - 5 ml / day.

Precautions.

To use caution in patients with diabetes (especially in the treatment of hepatic encephalopathy). When gastrocardiac syndrome should gradually increase the dose, to avoid flatulence; flatulence usually disappear on their own after 2-3 days of treatment. You can not assign to the background of abdominal pain, nausea and vomiting. When the diarrhea treatment cancel. Long-term treatment (more 6 Months) higher doses should regularly monitor the level of serum electrolytes.

Cooperation

Active substanceDescription of interaction
Calcium carbonateFKV. Reduces the drop in colonic pH, called lactulose, and prevents the development effect.
Magnesium carbonateFKV. Reduces the drop in colonic pH, called lactulose, and prevents the development effect.
NeomycinFMR: antagonizm. Reduces effect.

Back to top button